Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Dinney

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
The Journal of Urology|June 30, 2022
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta TumorsKelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
BJU International|February 20, 2024
Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomyRoberto Contieri, Wei Shen Tan, Valentina Grajales, et al.
European Urology Oncology|May 3, 2021
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy OutcomesPatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
Carcinogenesis|October 31, 2009
Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer riskMeng Chen, Adrian Cassidy, Jian Gu, et al.
European Urology Oncology|July 19, 2023
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder CancerWei Shen Tan, Ian M McElree, Facundo Davaro, et al.
The Journal of Urology|June 30, 2022
Reply by AuthorsKelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
BMJ Supportive & Palliative Care|September 2, 2017
Risk factors for falls in older patients with cancerXiaotao Zhang, Ming Sun, Suyu Liu, et al.
Genes & Cancer|October 15, 2016
Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer developmentMeng Chen, Nathaniel Rothman, Yuanqing Ye, et al.
The Journal of Urology|November 17, 2007
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancerWassim Kassouf, Peter C Black, Tomasz Tuziak, et al.
BJU International|March 24, 2018
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapyChinedu O Mmeje, Cooper R Benson, Graciela M Nogueras-González, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
The Journal of Urology|June 30, 2022
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta TumorsKelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
BJU International|February 20, 2024
Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomyRoberto Contieri, Wei Shen Tan, Valentina Grajales, et al.
European Urology Oncology|May 3, 2021
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy OutcomesPatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
Carcinogenesis|October 31, 2009
Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer riskMeng Chen, Adrian Cassidy, Jian Gu, et al.
European Urology Oncology|July 19, 2023
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder CancerWei Shen Tan, Ian M McElree, Facundo Davaro, et al.
The Journal of Urology|June 30, 2022
Reply by AuthorsKelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
BMJ Supportive & Palliative Care|September 2, 2017
Risk factors for falls in older patients with cancerXiaotao Zhang, Ming Sun, Suyu Liu, et al.
Genes & Cancer|October 15, 2016
Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer developmentMeng Chen, Nathaniel Rothman, Yuanqing Ye, et al.
The Journal of Urology|November 17, 2007
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancerWassim Kassouf, Peter C Black, Tomasz Tuziak, et al.
BJU International|March 24, 2018
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapyChinedu O Mmeje, Cooper R Benson, Graciela M Nogueras-González, et al.
Pageof 21